This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.


  Mobile version   RSS   Subscribe   Unsubscribe   Archive   Media Kit Jun. 19, 2012

   NAMCP   AAMCN    AAIHDS    CME/CEU    JMCM    Contact Us  


Targeting critical pathways

We are improving cancer treatment by developing monoclonal antibodies that target cancer stem cells.

Click Here to view the Journal of Managed Care Medicine


Online CME/CEU Programs

Multiple Myeloma: An Update on Diagnostic and Treatment Strategies

Advanced Treatment of Osteoporosis in Postmenopausal Women

Decreasing the Cost Burden of Fibromyalgia with Early Diagnosis and Management


Announcing the NAMCP Medical Directors Lung Cancer Resource Center. Click here to visit the website.

Be sure to check out the study results of Verinata's Non-Invasive Prenatal Technology. Click here to view the press release.

Click here to check out the "Latest in Clinical Nutrition" DVD available for purchase now!

Fall Managed Care Forum
November 8-9
Bellagio Hotel

 



 Managed Healthcare News
Click Here to visit the Population Health Management Institute

AMA wants higher Medicare payments
Chicago Tribune    Share    Share on FacebookTwitterShare on LinkedinE-mail article
While the fate of the Affordable Care Act hangs in the balance, American Medical Association President Dr. Peter Carmel argued that higher payments are needed for doctors who treat patients through the federal Medicare program. More

What is the Health Economic Impact of a Non-Invasive Prenatal Test?

Learn About Bridgehead International’s report, authored by Susan Garfield, on the clinical and economic utility of this test in this quarter’s JMCM, entitled “Clinical and Cost Consequences of Incorporating a Novel Non-Invasive Prenatal Test into the Diagnostic Pathway for Fetal Trisomies.


Parties strategize for dealing with Supreme Court healthcare decision
The New York Times    Share    Share on FacebookTwitterShare on LinkedinE-mail article
U.S. House Republicans are not waiting for the Supreme Court verdict on the new healthcare law to plot their strategic response. If the measure is not thrown out entirely, House leaders plan to force a vote immediately to repeal the law to reinforce their deep opposition to the legislation, opposition that has become central to their political identity. More

Employers' 'plan B' if health reform is axed
CNN    Share    Share on FacebookTwitterShare on LinkedinE-mail article
How Corporate America will react if the Supreme Court overturns the landmark 2010 healthcare reform law is a big, scary question mark. And that leaves more than 160 million people who get their insurance directly through their employers in the dark. Meanwhile, the health insurance industry and consumers are bracing for a possible big change. More

 FDA: New Treatments & Technology


US children getting more ADHD drugs, fewer antibiotics
Reuters    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The number of drugs dispensed to U.S. minors has dropped slightly over the past decade, bucking the rise in prescriptions to adults, according to a government report. Antibiotics use fell by 14 percent, suggesting efforts to curb rampant overuse of the drugs "may be working," researchers from the Food and Drug Administration write in the journal Pediatrics. More

FDA rebukes Advocate Health Care
Chicago Tribune    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The Food and Drug Administration has sharply criticized Advocate Health Care, the state's largest health system, for enrolling emergency room patients in a clinical trial without their permission. In a warning letter, the FDA questioned a study designed to evaluate the effectiveness of a sedative called etomidate. More


Nursing@
Georgetown


Nursing@Georgetown is a Master’s in Nursing program delivered online by Georgetown University’s renowned School of Nursing & Health Studies.
MORE
Our activities touch many lives
AstraZeneca is a global, innovation-driven, integrated biopharmaceutical company. We discover, develop, manufacture and market prescription medicines for cancer, cardiovascular, gastrointestinal and infection. MORE


 Oncology
Click Here to visit the Oncology Institute


'Hitch-hiking' cold virus may target, treat cancer
CBS News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Can the common cold one day help cure cancer? That's what scientists are hoping after a study reported on a promising new treatment in which a "hitch-hiking" virus sneaks up on tumors undetected. More

In 1 type of cancer, heavier men may live longer
Reuters    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Extra pounds may not be good for your health in general, but heavy men appear more likely to survive a particular form of immune system cancer, a study finds. The cancer in question is an aggressive form of non-Hodgkin lymphoma called diffuse large B-cell lymphoma. Non-Hodgkin lymphomas include a large group of cancers that affect the lymphatic system, a part of the immune system. More

 Prevention & Wellness
Click Here to visit the Center for Preventive Health and Lifestyle Medicine


Top heart doctors fret over new blood thinners
Reuters    Share    Share on FacebookTwitterShare on LinkedinE-mail article
For millions of heart patients, a pair of new blood thinners have been heralded as the first replacements in 60 years for warfarin. But growing complaints of risks and deaths tied to the new crop of drugs have made some top cardiologists hesitant to prescribe them. Some are proposing a more rigorous monitoring regimen for when they are used. More

Traces of virus in man cured of HIV trigger scientific debate
NPR    Share    Share on FacebookTwitterShare on LinkedinE-mail article
VideoBriefTop AIDS scientists are scratching their heads about new data from the most famous HIV patient in the world — at least to people in the AIDS community. Timothy Ray Brown, known as the Berlin patient, is thought to be the first patient ever to be cured of HIV infection. New data raise a question about whether there are minute traces of HIV in some tissues — not whole virus capable of replicating, but pieces of viral genes. More

HHS rethinking ban on gay male blood donors
MedPage Today    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Dozens of members of Congress have voiced support for having the Department of Health and Human Services study alternatives to the current blanket ban on blood and plasma donations from men who have sex with men. More

 Genomics and Biotech
Click Here to visit the Genomics, Biotech & Emerging Medical Technology Institute


Stroke patients see 'improvements' after stem cell trial
BBC News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The first patients to take part in a clinical trial of a stem cell treatment for stroke have seen reductions in their disability, according to doctors. Six patients in the west of Scotland had human stem cells inserted close to the damaged part of their brain. More

Doctors transplant vein grown from patient's own cells
ABC News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Scientists in Sweden are reporting a medical first: a vein grown in a lab for a 10-year-old girl using her body's own cells. Doctors are hailing the step as a milestone in tissue engineering, a field in which doctors grow windpipes, bladders, lungs and other organs to replace faulty ones while avoiding the dangerous, lifelong complications of organ transplants. More

Study: Stem cells can be harvested long after death
Agence France-Presse via Google News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Some stem cells can lay dormant for more than two weeks in a dead person and then be revived to divide into new, functioning cells, scientists in France said. The research, published in the journal Nature Communications, unlocks further knowledge about the versatility of these cells, touted as a future source to replenish damaged tissue. More

 Behavioral Health
Click Here to visit the Behavioral Health Institute


Secondhand smoke tied to more health effects
Reuters    Share    Share on FacebookTwitterShare on LinkedinE-mail article
People regularly exposed to secondhand smoke may have increased risks of dying from various causes, a long-term study from China suggests. Researchers found compared with adults who lived and worked in smoke-free environs, those exposed to secondhand smoke were more likely to die of heart disease or lung cancer over 17 years. More

Ecstasy-based treatment improves Parkinson's effects
Laboratory Equipment    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The illicit drug ecstasy is strongly associated with rave culture, but can a drug that makes people want to dance be used to develop medicines that curb involuntary movements in Parkinson's disease? A team led by a medicinal chemist at The University of Western Australia thinks it may be possible. More

FAST FACTS
"About 3,400 nonsmoking adults die of lung cancer as a result of breathing secondhand smoke, according to the American Cancer Society."
 
Managed Care eNews
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Christine Kraly, Content Editor, 469.420.2685   
Contribute news

This edition of the Managed Care eNews was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here -- it's free!
Recent issues
June 12, 2012
June 5, 2012
May 29, 2012
May 22, 2012



7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063